Filed in archive
Stem Cells
by ruth on January 31, 2009
The Telegraph reports of the continuing positive results on the use of stem cells in treating multiple sclerosis in conjunction with a drug called alemtuzumab. The study leader, Dr Richard Burt, descr...
Filed in archive
Information About
, Stem Cells
by ruth on January 31, 2009
Researchers have discovered that using titanium oxide nanotube implants with stem cells can help accelerate bone growth and healing.
During their research, the group of UC San Diego bioengineers and ...
Filed in archive
Diagnostics, Methodologies and Instrumentation
by ruth on January 30, 2009
Researchers from Draper Laboratories have developed an injectable nanosensor that can be injected into the skin to monitor an individual's blood-sugar level.
The material consists of 120-nanomete...
Filed in archive
Corporate and Industrial News
, Drugs, Vaccines and Therapeutics
, Stem Cells
by ruth on January 28, 2009
The FDA has approved the world's first clinical trial on the use of stem cell therapy for patients with acute spinal cord injury. Geron Corporation will conduct a Phase I multi-center trial design...
Filed in archive
Gene Therapy
by ruth on January 27, 2009
A study published in the journal Human Gene Therapy reports of the first clinical evidence that gene therapy reduces symptoms in patients with rheumatoid arthritis, based on data from two patients. Th...
Filed in archive
Genomics, Proteomics and Bioinformatics
by ruth on January 24, 2009
Based on a genetic study of 1,380 Europeans, reseachers have identified 3 genes that increase risk of early-onset obesity in children, and morbid obesity in adults.
"The idea was not just to look...
Filed in archive
Energy, Environment and Ecology
by ruth on January 22, 2009
Ben-Gurion University of the Negev (BGU) and Primafuel, Inc., a California-based company that develops renewable fuels, have entered a multi-year, multi-million dollar technology-licensing and develop...
Filed in archive
Drugs, Vaccines and Therapeutics
by ruth on January 20, 2009
A new antimicrobial compound has been isolated from the freshwater animal Hydra. The compound, called hydramacin-1, shares virtually no similarity with any other known antibacterial proteins except fo...
Filed in archive
Drugs, Vaccines and Therapeutics
by ruth on January 16, 2009
The FDA has approved a new drug for the management of fibromyalgia. Savella™ (milnacipran HCl), developed by FOREST LABORATORIES, Inc.and Cypress Bioscience, Inc., is a selective serotonin and norepin...
Filed in archive
Biotech Hubs and Facilities
, Microbiology
by ruth on January 14, 2009
A new molecular ecology facility at Mason called the MicroBiome Analysis Center (MBAC) aims to catalog the human microbiome - the population of microorganisms living within the human body- and try to ...
Filed in archive
Corporate and Industrial News
by ruth on January 13, 2009
BIO is inviting nominations to the Biotech Humanitarian Award. The award aims to recognize a biotech professional- a scientist, researcher, academic, entrepreneur, financier, philanthropist or educato...
Filed in archive
Food and Agriculture
by ruth on January 8, 2009
In an animal study, researchers attribute the chemo-preventive properties of black raspberries to anthocyanins, a class of flavonoids found in the fruit. This is one of the first experiments demonstra...
Filed in archive
Meetings and Other Events
by Gloria Gamat on January 6, 2009
What: 3rd Annual Business of Biotech Conference
When: 7:30 a.m. to 12:30 p.m. January 29, 2009
Where: Vincent A. Stabile Research Building at Moffitt Cancer Center Tampa, Florida
The 3rd Annual Bus...
